The Natural Chemotherapeutics Research Institute is one of the beneficiaries of an investment by The Presidential Scientific Initiative on Epidemics (PRESIDE), into research studies to evaluate therapeutics that have potential to contribute to the fight of the SARS-COV-2 (COVID-19) pandemic.
Today we are launching the clinical trial to assess the effectiveness of a natural home grown traditional product for the treatment of COVID 19. This clinical trial is the first of its kind in Uganda that will be testing a...
Dr. Monica Musenero during the 2nd Scientific Graduation Ceremony held today 8th January, 2021 at the NCRI Grounds.
Director’s Speech at the 2nd Scientific Graduation of Occupational Herbalists
Request for Standard Protocol for Phase III Clinical Trials and its Annexes (DSMB-Investigators Brochure and 12 Standard Operating Procedures
A multi-centre, randomized, double-blind, clinical trial to evaluate the safety and efficacy of herbal medicine compared to the standard of care for the treatment of hospitalized patients with mild to moderate cases of novel coronavirus disease (COVID-19).